Form EFFECT - Notice of Effectiveness

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form EFFECT - Notice of Effectiveness

Oculis (NASDAQ:OCSAW)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Oculis Charts.

Oculis (NASDAQ:OCSAW)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Oculis Charts.

Oculis Holding AG News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 January 2025 (2 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 3 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 29 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 6 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 10 June 2024 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 31 May 2024 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 8 May 2024 (10 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 8 May 2024 (10 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 8 May 2024 (10 months ago) • Edgar (US Regulatory)

More Oculis Holding AG News Articles

Valiant Eagle (PK)

Anavex Life Sciences

Rennova Health (CE)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Global Developments (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions